Home › Post-Traumatic Stress Disorder › NCT07401225

TMS for PTSD in Youth

Transcranial Magnetic Stimulation as Treatment for Persistent PTSD in Texas Youth

Who can join

Ages 12 to 20 · All sexes

Inclusion Criteria:

1. Males and females; Age 12-20
2. Have previously completed at least 9 sessions of trauma-focused therapy in our clinical trial or in the community
3. Have current self-reported symptom score of 20 or greater on the UCLA PTSD Reaction index
4. Willing to attend 10 TMS treatment sessions within a 30-day period
5. Fluent in English

Exclusion Criteria:

1. History of seizures
2. History of head injury with loss of consciousness and concussive sequelae
3. Brain abnormality such as tumor or other observable abnormality
4. Currently receiving psychotherapy or TMS treatment
5. Currently pregnant
6. MRI contraindications (metal in body, orthodontic braces)
7. Diagnosis of bipolar 1 or a psychotic disorder

About the study

The purpose of this study is to test whether transcranial magnetic stimulation, or TMS, is an acceptable and helpful treatment for ongoing symptoms of posttraumatic stress syndrome disorder (PTSD) in 12-20 year olds. Ongoing PTSD refers to symptoms that continue after completing trauma-focused psychotherapy. About 1 in 4 patients need additional help to overcome PTSD after completing psychotherapy. Currently, scientists do not know the best way to help adolescents with persistent PTSD, and this study will test TMS as a possible treatment, and hopefully lead to future studies including more people.

What is being tested

• MagPro R30 with robotic arm (device)

Sponsor: The University of Texas Health Science Center at San Antonio · Participants: 20 · Started: May 9, 2026

Contact the study team

• Amy S Garrett, PhD · Phone: 210-567-8189

Official record on ClinicalTrials.gov — NCT07401225

Locations in the U.S.

Conditions

• Post-Traumatic Stress Disorder

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.